Identification Generic Name (1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid DrugBank Accession Number DB07713 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid (DB07713) ×  Close Weight Average: 399.398  Monoisotopic: 399.090544643  Chemical Formula C 17 H 22 NO 6 PS Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Neutrophil collagenase Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Biphenyls and derivatives Direct Parent Biphenyls and derivatives Alternative Parents Benzenesulfonamides  /  Benzenesulfonyl compounds  /  Phenoxy compounds  /  Methoxybenzenes  /  Anisoles  /  Alkyl aryl ethers  /  Organosulfonamides  /  Organic phosphonic acids  /  Aminosulfonyl compounds  /  Organopnictogen compounds  /  Organophosphorus compounds  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives 
 
 
  show 4 more Substituents Alkyl aryl ether  /  Aminosulfonyl compound  /  Anisole  /  Aromatic homomonocyclic compound  /  Benzenesulfonamide  /  Benzenesulfonyl group  /  Biphenyl  /  Ether  /  Hydrocarbon derivative  /  Methoxybenzene  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organic sulfonic acid or derivatives  /  Organonitrogen compound  /  Organooxygen compound  /  Organophosphonic acid  /  Organophosphonic acid derivative  /  Organophosphorus compound  /  Organopnictogen compound  /  Organosulfonic acid amide  /  Organosulfonic acid or derivatives  /  Organosulfur compound  /  Phenol ether  /  Phenoxy compound  /  Sulfonyl 
 
 
  show 16 more Molecular Framework Aromatic homomonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key BZVYQWLRCHLAGK-KRWDZBQOSA-N InChI InChI=1S/C17H22NO6PS/c1-12(2)17(25(19,20)21)18-26(22,23)16-10-6-14(7-11-16)13-4-8-15(24-3)9-5-13/h4-12,17-18H,1-3H3,(H2,19,20,21)/t17-/m0/s1 IUPAC Name [(1S)-1-{4'-methoxy-[1,1'-biphenyl]-4-sulfonamido}-2-methylpropyl]phosphonic acid SMILES COC1=CC=C(C=C1)C1=CC=C(C=C1)S(=O)(=O)N[C@H](C(C)C)P(O)(O)=O References General References Not Available External Links PubChem Compound 6540261 PubChem Substance 99444184 ChemSpider 5022660 BindingDB 12073 ChEMBL CHEMBL382201 ZINC ZINC000013680269 PDBe Ligand EIN PDB Entries 1zs0 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.461 mg/mL ALOGPS logP 1.43 ALOGPS logP 2.43 Chemaxon logS -2.9 ALOGPS pKa (Strongest Acidic) 1.48 Chemaxon pKa (Strongest Basic) -4.8 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 112.93 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 98.92 m 3 ·mol -1 Chemaxon Polarizability 38.92 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9696 Blood Brain Barrier - 0.5296 Caco-2 permeable - 0.5954 P-glycoprotein substrate Non-substrate 0.7337 P-glycoprotein inhibitor I Non-inhibitor 0.7975 P-glycoprotein inhibitor II Non-inhibitor 0.8519 Renal organic cation transporter Non-inhibitor 0.9236 CYP450 2C9 substrate Non-substrate 0.5626 CYP450 2D6 substrate Non-substrate 0.8007 CYP450 3A4 substrate Non-substrate 0.5293 CYP450 1A2 substrate Non-inhibitor 0.6815 CYP450 2C9 inhibitor Inhibitor 0.5 CYP450 2D6 inhibitor Non-inhibitor 0.9057 CYP450 2C19 inhibitor Inhibitor 0.5454 CYP450 3A4 inhibitor Non-inhibitor 0.7912 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.5201 Ames test Non AMES toxic 0.7036 Carcinogenicity Non-carcinogens 0.5219 Biodegradation Not ready biodegradable 0.9967 Rat acute toxicity 2.7417 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9509 hERG inhibition (predictor II) Non-inhibitor 0.7068    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 810 N/A N/A A30912 Ki (nM) 700 7.5 25 A30911 
 
 
  Details 
 
 
   Binding Properties 1.  Neutrophil collagenase Kind Protein Organism Humans Pharmacological action Unknown General Function Zinc ion binding Specific Function Can degrade fibrillar type I, II, and III collagens. Gene Name MMP8 Uniprot ID P22894 Uniprot Name Neutrophil collagenase Molecular Weight 53411.72 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:25 / Updated at June 12, 2020 16:52 